PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1643640
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1643640
Pharmacogenomics Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2032)
The global pharmacogenomics market is projected to grow from USD 6.1 billion in 2024 to USD 10.0 billion by 2032, reflecting a compound annual growth rate (CAGR) of 6.6% during 2025-2032. This growth is fueled by the increasing prevalence of infectious diseases and cancer, alongside advancements in personalized medicine that enhance drug efficacy and safety.
Key Insights
The rising incidence of infectious diseases and various cancers is driving demand for pharmacogenomics, as personalized medicine plays a pivotal role in developing effective treatment strategies.
There is a growing global shift toward preventive healthcare, with personalized medicine at the forefront. Pharmacogenomics tailors treatments based on individual genetic profiles, significantly improving therapeutic outcomes.
Technological advancements, particularly in next-generation sequencing (NGS), have improved the efficiency and affordability of genetic analysis. NGS enables comprehensive sequencing, aiding in the identification of genetic variations that influence drug responses.
Pharmacogenomics helps predict individual responses to medications, reducing the occurrence of adverse drug reactions. This predictive capability enhances patient safety and improves healthcare delivery.
Research organizations are expected to be the largest end-user category, as extensive studies on gene-drug interactions and tailored therapeutic approaches continue to expand.
North America is anticipated to dominate the market, driven by advanced healthcare infrastructure, significant investments in research and development, and the early adoption of innovative technologies.
The Asia-Pacific region is projected to experience the fastest growth due to increasing healthcare awareness, rising prevalence of chronic diseases, and supportive government initiatives promoting personalized medicine.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market Size Breakdown, by Service
- 1.4.2. Market Size Breakdown, by Application
- 1.4.3. Market Size Breakdown, by Technology
- 1.4.4. Market Size Breakdown, by End User
- 1.4.5. Market Size Breakdown, by Region
- 1.4.6. Market Size Breakdown, by Country
- 1.5. Market Data Reporting Unit
- 1.5.1. Revenue
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence Database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Industry Background
- 5.2. Market Dynamics
- 5.2.1. Trends
- 5.2.2. Drivers
- 5.2.3. Restraints/Challenges
- 5.2.4. Emerging Economies and Key Opportunities
- 5.2.5. Impact Analysis of Drivers/Restraints
- 5.3. Impact of COVID-19
- 5.4. Sociopolitical Impact
- 5.5. Porter's Five Forces Analysis
- 5.5.1. Bargaining Power of Buyers
- 5.5.2. Bargaining Power of Suppliers
- 5.5.3. Threat of New Entrants
- 5.5.4. Intensity of Rivalry
- 5.5.5. Threat of Substitutes
- 5.6. Innovation and Technology Trends
- 5.7. Economic and Regulatory Impact
- 5.8. Market Entry Strategies
Chapter 6. Competitive Landscape
- 6.1. List of Market Players and their Offerings
- 6.2. Competitive Benchmarking of Key Players
- 6.3. Recent Strategic Developments by Key Players
- 6.4. Company Leadership Matrix
Chapter 7. Global Market
- 7.1. Overview
- 7.2. Market Revenue, by Service (2019-2032)
- 7.3. Market Revenue, by Application (2019-2032)
- 7.4. Market Revenue, by Technology (2019-2032)
- 7.5. Market Revenue, by End User (2019-2032)
- 7.6. Market Revenue, by Region (2019-2032)
Chapter 8. North America Market
- 8.1. Overview
- 8.2. Market Revenue, by Service (2019-2032)
- 8.3. Market Revenue, by Application (2019-2032)
- 8.4. Market Revenue, by Technology (2019-2032)
- 8.5. Market Revenue, by End User (2019-2032)
- 8.6. Market Revenue, by Country (2019-2032)
Chapter 9. Europe Market
- 9.1. Overview
- 9.2. Market Revenue, by Service (2019-2032)
- 9.3. Market Revenue, by Application (2019-2032)
- 9.4. Market Revenue, by Technology (2019-2032)
- 9.5. Market Revenue, by End User (2019-2032)
- 9.6. Market Revenue, by Country (2019-2032)
Chapter 10. Asia-Pacific Market
- 10.1. Overview
- 10.2. Market Revenue, by Service (2019-2032)
- 10.3. Market Revenue, by Application (2019-2032)
- 10.4. Market Revenue, by Technology (2019-2032)
- 10.5. Market Revenue, by End User (2019-2032)
- 10.6. Market Revenue, by Country (2019-2032)
Chapter 11. Latin America Market
- 11.1. Overview
- 11.2. Market Revenue, by Service (2019-2032)
- 11.3. Market Revenue, by Application (2019-2032)
- 11.4. Market Revenue, by Technology (2019-2032)
- 11.5. Market Revenue, by End User (2019-2032)
- 11.6. Market Revenue, by Country (2019-2032)
Chapter 12. Middle East and Africa Market
- 12.1. Overview
- 12.2. Market Revenue, by Service (2019-2032)
- 12.3. Market Revenue, by Application (2019-2032)
- 12.4. Market Revenue, by Technology (2019-2032)
- 12.5. Market Revenue, by End User (2019-2032)
- 12.6. Market Revenue, by Country (2019-2032)
Chapter 13. Company Profiles
Chapter 14. Appendix
- 14.1. Sources and References
- 14.2. Related Reports
